Stem, Inc. (NYSE:STEM) Given Consensus Recommendation of “Reduce” by Analysts

Shares of Stem, Inc. (NYSE:STEM) have been given an average recommendation of “Reduce” by the six research firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating and five have given a hold rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $17.60.

Several equities analysts recently issued reports on STEM shares. UBS Group lifted their price target on shares of Stem from $16.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, October 31st. Susquehanna lifted their target price on shares of Stem from $12.00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, October 13th. Weiss Ratings reissued a “hold (c-)” rating on shares of Stem in a report on Monday, December 29th. Barclays reaffirmed a “reduce” rating and set a $18.00 price target (up from $13.00) on shares of Stem in a report on Friday, October 31st. Finally, Roth Mkm set a $23.00 price objective on Stem and gave the company a “neutral” rating in a research report on Thursday, October 30th.

Stem News Summary

Here are the key news stories impacting Stem this week:

• Neutral Sentiment: Local & higher-education STEM program stories highlight continued public interest in STEM education (unlikely to directly affect Stem, Inc.’s energy-storage business). Coverage includes K–12 and college investments and outreach events that support the broader STEM talent pipeline. Read More., Read More., Read More., Read More., Read More., Read More., and Read More..
• Neutral Sentiment: Broader “stem cell” science and medical research items dominate health coverage but do not relate to Stem, Inc.’s energy-storage operations. Examples: ethics debate on stem cells for autism, early neural‑stem‑cell research in Leigh syndrome, drug combos to protect stem‑cell heart grafts, and a bone‑marrow stem‑cell explainer. Read More., Read More., Read More., Read More..
• Neutral Sentiment: STEM job-market recognition signals a healthy labor demand for technical roles generally, which is a long-term tailwind for electrification and storage demand but is not an immediate driver of Stem, Inc. shares. Read More..
• Negative Sentiment: Recent quarterly results remain the primary near‑term negative catalyst: the company reported a larger‑than‑expected EPS loss and missed revenue estimates, with analysts still forecasting negative EPS for the year—these fundamentals are consistent with downward pressure on the stock.
• Negative Sentiment: Technical/market context is bearish: shares are trading below near‑term highs, near their 50‑ and 200‑day moving averages, market cap is relatively small and the stock carries a negative P/E—factors that can amplify volatility and make the stock more sensitive to earnings or guidance misses. (Trading volume is around recent averages.)

Stem Trading Down 5.9%

NYSE STEM opened at $15.64 on Monday. Stem has a 1-year low of $5.81 and a 1-year high of $32.23. The company has a market capitalization of $131.22 million, a price-to-earnings ratio of -1.15 and a beta of 1.29. The stock’s 50 day moving average is $17.55 and its two-hundred day moving average is $17.50.

Insider Buying and Selling

In related news, CAO Rahul Shukla sold 3,674 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $16.21, for a total value of $59,555.54. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 10.17% of the company’s stock.

Hedge Funds Weigh In On Stem

Several institutional investors have recently modified their holdings of the stock. IFP Advisors Inc increased its holdings in Stem by 258.1% in the third quarter. IFP Advisors Inc now owns 1,479 shares of the company’s stock worth $26,000 after buying an additional 1,066 shares during the last quarter. Virtu Financial LLC grew its position in Stem by 11.0% in the third quarter. Virtu Financial LLC now owns 12,856 shares of the company’s stock worth $225,000 after acquiring an additional 1,279 shares in the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Stem during the 3rd quarter worth $55,000. Vanguard Group Inc. raised its holdings in shares of Stem by 2.2% during the 3rd quarter. Vanguard Group Inc. now owns 395,223 shares of the company’s stock valued at $6,924,000 after purchasing an additional 8,468 shares in the last quarter. Finally, GSA Capital Partners LLP acquired a new stake in shares of Stem in the 3rd quarter valued at $207,000. 61.63% of the stock is currently owned by institutional investors and hedge funds.

About Stem

Stem, Inc is a technology company specializing in AI-driven energy storage and optimization solutions for commercial, industrial and utility customers. The company delivers integrated hardware and software systems that enable clients to manage energy consumption, reduce peak demand charges and provide ancillary services to the power grid. By combining battery storage hardware with advanced machine-learning algorithms, Stem helps organizations align energy usage with cost-saving opportunities while supporting grid reliability and renewable integration.

At the core of Stem’s offering is its Athena software platform, which uses real-time data and predictive analytics to forecast energy needs and automatically dispatch stored energy when it is most valuable.